Vasopressin as a Stress Hormone

Stress: Neuroendocrinology and Neurobiology

Volumn 2, Issue , 2017, Pages 97-108

  Antoni, F A ^a  

^a EGIS PHARMACEUTICALS LTD   (Hungary)

Author keywords

Arthritis; Autoimmune disorders; Corticotropin releasing factor; Dexamethasone nonsuppression; HPA axis; Interleukin 6; Intracellular signaling; Personalized medicine; Vasopressin receptors

Indexed keywords

EID: 85021863991     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-802175-0.00009-7     Document Type: Chapter

References (120)

1. Acher R. Water homeostasis in the living: molecular organization, osmoregulatory reflexes and evolution. Ann Endocrinol Paris 2002, 63:197-218.
2. Aguilera G. The hypothalamic-pituitary-adrenal axis and neuroendocrine responses to stress. Handb Neuroendocrinol 2012, 175-196.
3. Aguilera G., Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept 2000, 96:23-29.
4. Antoni F.A. Hypothalamic regulation of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 1986, 7:351-378.
5. Antoni F.A. Receptors mediating the CRH effects of vasopressin and oxytocin. Ann NY Acad Sci 1987, 512:195-204.
6. Antoni F.A. Vasopressinergic control of anterior pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 1993, 14:76-122.
7. Antoni F.A. Calcium checks cyclic AMP - mechanism of corticosteroid feedback in adenohypophysial corticotrophs. J Neuroendocrinol 1996, 8:659-672.
8. Antoni F.A. Molecular diversity of cyclic AMP signaling. Front Neuroendocrinol 2000, 21:103-132.
9. Antoni F.A. Role of pituitary regulation. Encyclopedia of Stress, Second Edition 2007, Vol. 3:127-131. Oxford: Academic Press. G. Fink (Ed.).
10. Antoni F.A. New paradigms in cAMP signalling. Mol Cell Endocrinol 2012, 353:3-9.
11. Balanescu S., Kopp P., Gaskill M.B., Morgenthaler N.G., Schindler C., Rutishauser J. Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States. J Clin Endocrinol Metab 2011, 96:1046-1052.
12. Balázsfi D., Pintér O., Klausz B., et al. Restoration of peripheral V2 receptor vasopressin signaling fails to correct behavioral changes in Brattleboro rats. Psychoneuroendocrinology 2015, 51:11-23.
13. Barberis C., Tribollet E. Vasopressin and oxytocin receptors in the central nervous system. Crit Rev Neurobiol 1996, 10:119-154.
14. Berkowitz B.A., Sherman S. Characterization of vasopressin analgesia. J Pharmacol Exp Ther 1982, 220:329-334.
15. Bridges R.J., Rummel W., Wollenberg P. Effects of vasopressin on electrolyte transport across isolated colon from normal and dexamethasone-treated rats. J Physiol 1984, 355:11-23.
16. Brownstein M.J., Russell J.T., Gainer H. Synthesis, transport, and release of posterior pituitary hormones. Science 1980, 207:373-378.
17. Bulbul M., Babygirija R., Cerjak D., Yoshimoto S., Ludwig K., Takahashi T. Hypothalamic oxytocin attenuates CRF expression via GABA(A) receptors in rats. Brain Res 2011, 1387:39-45.
18. Burbach J.P.H., Adan R.A.H., Lolait S.J., et al. Molecular neurobiology and pharmacology of the vasopressin oxytocin receptor family. Cell Mol Neurobiol 1995, 15:573-595.
19. Caldwell H.K., Lee H.J., Macbeth A.H., Young W.S. Vasopressin: behavioral roles of an "original" neuropeptide. Prog Neurobiol 2008, 84:1-24.
20. Chakfe Y., Zhang Z., Bourque C.W. IL-1beta directly excites isolated rat supraoptic neurons via upregulation of the osmosensory cation current. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1183-R1190.
21. Chen J., Aguilera G. Vasopressin protects hippocampal neurones in culture against nutrient deprivation or glutamate-induced apoptosis. J Neuroendocrinol 2010, 22:1072-1081.
22. Craighead M., Milne R., Campbell-Wan L., et al. Characterization of a novel and selective V1B receptor antagonist. Prog Brain Res 2008, 170:527-535.
23. Cui Z., Gerfen C.R., Young W.S. Hypothalamic and other connections with dorsal CA2 area of the mouse hippocampus. J Comp Neurol 2013, 521:1844-1866.
24. Curley K.O., Neuendorff D.A., Lewis A.W., Rouquette F.M., Randel R.D., Welsh T.H. The effectiveness of vasopressin as an ACTH secretagogue in cattle differs with temperament. Physiol Behav 2010, 101:699-704.
25. Day T.A., Sibbald J.R. Noxious somatic stimuli excite neurosecretory vasopressin cells via A1 cell group. Am J Physiol 1990, 258:R1516-R1520.
26. de Vries G.J., Miller M.A. Anatomy and function of extrahypothalamic vasopressin systems in the brain. Prog Brain Res 1998, 119:3-20.
27. Engelmann M., Landgraf R., Wotjak C.T. The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited. Front Neuroendocrinol 2004, 25:132-149.
28. Enhorning S., Struck J., Wirfalt E., Hedblad B., Morgenthaler N.G., Melander O. Plasma copeptin, a unifying factor behind the metabolic syndrome. J Clin Endocrinol Metab 2011, 96:E1065-E1072.
29. Fink G. Encyclopedia of Stress, Second Edition 2007, Oxford: Academic Press.
30. Franceschini R., Leandri M., Cataldi A., et al. Raised plasma arginine vasopressin concentrations during cluster headache attacks. J Neurol Neurosurg Psychiatry 1995, 59:381-383.
31. Gainer H. Cell-type specific expression of oxytocin and vasopressin genes: an experimental odyssey. J Neuroendocrinol 2012, 24:528-538.
32. Gillespie C.F., Nemeroff C.B. Hypercortisolemia and depression. Psychosom Med 2005, 67(suppl 1):S26-S28.
33. Gilman A.G. Nobel Lecture. G proteins and regulation of adenylyl cyclase. Biosci Rep 1995, 15:65-97.
34. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001, 81:629-683.
35. Goncharova N.D. Stress responsiveness of the hypothalamic-pituitary-adrenal axis: age-related features of the vasopressinergic regulation. Front Endocrinol (Lausanne) 2013, 4:26.
36. Gouzenes L., Dayanithi G., Moos F.C. Vasopressin(4-9) fragment activates V1a-type vasopressin receptor in rat supraoptic neurones. Neuroreport 1999, 10:1735-1739.
37. Greenwood M., Greenwood M.P., Mecawi A.S., et al. Transcription factor CREB3L1 mediates cAMP and glucocorticoid regulation of arginine vasopressin gene transcription in the rat hypothalamus. Mol Brain 2015, 8:68.
38. Griebel G., Holsboer F. Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?. Nat Rev Drug Discov 2012, 11:462-478.
39. Grinevich V., Knobloch-Bollmann H.S., Eliava M., Busnelli M., Chini B. Assembling the puzzle: pathways of oxytocin signaling in the brain. Biol Psychiatry 2016, 79:155-164.
40. Guillon G., Grazzini E., Andrez M., et al. Vasopressin: a potent autocrine/paracrine regulator of mammal adrenal functions. Endocr Res 1998, 24:703-710.
41. Hall R.A., Premont R.T., Lefkowitz R.J. Heptahelical receptor signaling: beyond the G protein paradigm. J Cell Biol 1999, 145:927-932.
42. Hamamura M., Shibuki K., Yagi K. Noxious inputs to supraoptic neurosecretory cells in the rat. Neurosci Res 1984, 2:49-61.
43. Hanley M.R., Benton H.P., Lightman S.L., et al. A vasopressin-like peptide in the mammalian sympathetic nervous system. Nature 1984, 309:258-261.
44. Hitti F.L., Siegelbaum S.A. The hippocampal CA2 region is essential for social memory. Nature 2014, 508:88-92.
45. Jalink K., Moolenaar W.H. G protein-coupled receptors: the inside story. Bioessays 2010, 32:13-16.
46. Jankord R., Zhang R., Flak J.N., Solomon M.B., Albertz J., Herman J.P. Stress activation of IL-6 neurons in the hypothalamus. Am J Physiol Regul Integr Comp Physiol 2010, 299:R343-R351.
47. Kannan H., Yamashita H., Koizumi K., Brooks C.M. Neuronal activity of the cat supraoptic nucleus is influenced by muscle small diameter afferent (groups III and IV) receptors. Proc Natl Acad Sci USA 1988, 85:5744-5748.
48. Kashiwazaki A., Fujiwara Y., Tsuchiya H., Sakai N., Shibata K., Koshimizu T.-A. Subcellular localization and internalization of the vasopressin V-1B receptor. Eur J Pharmacol 2015, 765:291-299.
49. Katan M., Christ-Crain M. The stress hormone copeptin: a new prognostic biomarker in acute illness. Swiss Med Wkly 2010, 140:w13101.
50. Keller-Wood M.B., Dallman M.F. Corticosteroid inhibition of ACTH secretion. Endocr Rev 1984, 5:1-23.
51. Kendler K.S., Weitzman R.E., Fisher D.A. The effect of pain on plasma arginine vasopressin concentrations in man. Clin Endocrinol (Oxf) 1978, 8:89-94.
52. Kiss J.Z., Van Eekelen J.A., Reul J.M., Westphal H.M., De Kloet E.R. Glucocorticoid receptor in magnocellular neurosecretory cells. Endocrinology 1988, 122:444-449.
53. Koshimizu T.-A., Nakamura K., Egashira N., Hiroyama M., Nonoguchi H., Tanoue A. Vasopressin V1a and V1b receptors: from molecules to physiological systems. Physiol Rev 2012, 92:1813-1864.
54. Kovács K.J., Földes A., Sawchenko P.E. Glucocorticoid negative feedback selectively targets vasopressin transcription in parvocellular neurosecretory neurons. J Neurosci 2000, 20:3843-3852.
55. Krishnan K.R.R., Rayasam K., Reed D., et al. The corticotropin releasing factor stimulation test in patients with major depression: relationship to dexamethasone suppression test results. Depression 1993, 1:133-136.
56. Kruk M.R., Halász J., Meelis W., Haller J. Fast positive feedback between the adrenocortical stress response and a brain mechanism involved in aggressive behavior. Behav Neurosci 2004, 118:1062-1070.
57. Kvetnansky R., McCarty R. Adrenal medulla. Encyclopedia of Stress, Second Edition 2007, Vol. 3. Oxford: Academic Press. G. Fink (Ed.).
58. Lim M.C., Shipston M.J., Antoni F.A. Posttranslational modulation of glucocorticoid feedback inhibition at the pituitary level. Endocrinology 2002, 143:3796-3801.
59. Ludwig M., Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat Rev Neurosci 2006, 7:126-136.
60. Ma X.M., Aguilera G. Differential regulation of corticotropin-releasing hormone and vasopressin transcription by glucocorticoids. Endocrinology 1999, 140:5642-5650.
61. Makara G.B., Antoni F.A., Stark E., Kárteszi M. Hypothalamic organization of CRF containing structures. Neuroendocr Perspect 1984, 3:71-110.
62. Manning M., Misicka A., Olma A., et al. Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J Neuroendocrinol 2012, 24:609-628.
63. Mason D. Genetic variation in the stress response susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunol Today 1991, 12:57-60.
64. McEwen B.S., Gianaros P.J. Stress- and allostasis-induced brain plasticity. Annu Rev Med 2011, 62:431-445.
65. Millan M.J., Schmauss C., Millan M.H., Herz A. Vasopressin and oxytocin in the rat spinal cord: analysis of their role in the control of nociception. Brain Res 1984, 309:384-388.
66. Mogil J.S., Sorge R.E., LaCroix-Fralish M.L., et al. Pain sensitivity and vasopressin analgesia are mediated by a gene-sex-environment interaction. Nat Neurosci 2011, 14:1569-1573.
67. Morand E.F., Leech M. Hypothalamic-pituitary-adrenal axis regulation of inflammation in rheumatoid arthritis. Immunol Cell Biol 2001, 79:395-399.
68. Morgenthaler N.G., Struck J., Jochberger S., Dunser M.W. Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 2008, 19:43-49.
69. Munck A., Guyre P.M., Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984, 5:25-44.
70. Munck A., Náray-Fejes-Tóth A. Glucocorticoids and stress: permissive and suppressive actions. Ann NY Acad Sci 1994, 746:115-130. discussion 131-113.
71. Murgatroyd C., Spengler D. Epigenetic programming of the HPA axis: early life decides. Stress 2011, 14:581-589.
72. Murphy D., Konopacka A., Hindmarch C., et al. The hypothalamic-neurohypophyseal system: from genome to physiology. J Neuroendocrinol 2012, 24:539-553.
73. Nestor C.E., Ottaviano R., Reinhardt D., et al. Rapid reprogramming of epigenetic and transcriptional profiles in mammalian culture systems. Genome Biol 2015, 16:11.
74. Niermann H., Amiry-Moghaddam M., Holthoff K., Witte O.W., Ottersen O.P. A novel role of vasopressin in the brain: modulation of activity-dependent water flux in the neocortex. J Neurosci 2001, 21:3045-3051.
75. Ottenhausen M., Bodhinayake I., Banu M.A., Stieg P.E., Schwartz T.H. Vincent du Vigneaud: following the sulfur trail to the discovery of the hormones of the posterior pituitary gland at Cornell Medical College. J Neurosurg 2015, 1-5.
76. Pacak K., Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocr Rev 2001, 22:502-548.
77. Pagani J.H., Zhao M., Cui Z., et al. Role of the vasopressin 1b receptor in rodent aggressive behavior and synaptic plasticity in hippocampal area CA2. Mol Psychiatry 2015, 20:490-499.
78. Peters A., Conrad M., Hubold C., Schweiger U., Fischer B., Fehm H.L. The principle of homeostasis in the hypothalamus-pituitary-adrenal system: new insight from positive feedback. Am J Physiol Regul Integr Comp Physiol 2007, 293:R83-R98.
79. Plotsky P.M. Pathways to the secretion of adrenocorticotropin: a view from the portal. J Neuroendocrinol 1991, 3:1-9.
80. Pouzet B., Serradeil-Le Gal C., Bouby N., Maffrand J.P., Le Fur G., Bankir L. Selective blockade of vasopressin V-2 receptors reveals significant V-2-mediated water reabsorption in Brattleboro rats with diabetes insipidus. Nephrol Dial Transplant 2001, 16:725-734.
81. Radley J.J., Sawchenko P.E. Evidence for involvement of a limbic paraventricular hypothalamic inhibitory network in hypothalamic-pituitary-adrenal axis adaptations to repeated stress. J Comp Neurol 2015, 523:2769-2787.
82. Raggenbass M. Overview of cellular electrophysiological actions of vasopressin. Eur J Pharmacol 2008, 583:243-254.
83. Reijmers L.G., Baars A.M., Burbach J.P., Spruijt B.M., van Ree J.M. Delayed effect of the vasopressin metabolite VP4-8 on the social memory of sexually naive male rats. Psychopharmacology (Berl) 2001, 154:408-414.
84. Reijmers L.G., van Ree J.M., Spruijt B.M., Burbach J.P., De Wied D. Vasopressin metabolites: a link between vasopressin and memory?. Prog Brain Res 1998, 119:523-535.
85. Ren X.R., Reiter E., Ahn S., Kim J., Chen W., Lefkowitz R.J. Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor. Proc Natl Acad Sci USA 2005, 102:1448-1453.
86. Rood B.D., Stott R.T., You S., Smith C.J., Woodbury M.E., De Vries G.J. Site of origin of and sex differences in the vasopressin innervation of the mouse (Mus musculus) brain. J Comp Neurol 2013, 521:2321-2358.
87. Roper J.A., O'Carroll A.M., Young W.S., Lolait S.J. The vasopressin Avpr1b receptor: molecular and pharmacological studies. Stress 2011, 14:98-115.
88. Satoh K., Oti T., Katoh A., et al. In vivo processing and release into the circulation of GFP fusion protein in arginine vasopressin enhanced GFP transgenic rats: response to osmotic stimulation. FEBS J 2015, 282:2488-2499.
89. Schlosser S.F., Almeida O.F.X., Patchev V.K., Yassouridis A., Elands J. Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1ß type. Endocrinology 1994, 135:2058-2063.
90. Schorscher-Petcu A., Sotocinal S., Ciura S., et al. Oxytocin-induced analgesia and scratching are mediated by the Vasopressin-1A receptor in the mouse. J Neurosci 2010, 30:8274-8284.
91. Seger M.A., Burbach J.P. The presence and in vivo biosynthesis of fragments of CPP (the C-terminal glycopeptide of the rat vasopressin precursor) in the hypothalamo-neurohypophyseal system. Peptides 1987, 8:757-762.
92. Selye H. Stress in Health and Disease 1976, Oxford: Butterworth-Heinemann Ltd.
93. Serradeil-Le Gal C., Wagnon J., Tonnerre B., et al. An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders. CNS Drug Rev 2005, 11:53-68.
94. Serrats J., Schiltz J.C., Garcia-Bueno B., van Rooijen N., Reyes T.M., Sawchenko P.E. Dual roles for perivascular macrophages in immune-to-brain signaling. Neuron 2010, 65:94-106.
95. Silverman M.N., Sternberg E.M. Glucocorticoid regulation of inflammation and its behavioral and metabolic correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann NY Acad Sci 2012, 1261:55-63.
96. Slattery D.A., Neumann I.D. No stress please! Mechanisms of stress hyporesponsiveness of the maternal brain. J Physiol 2008, 586:377-385.
97. Sofroniew M.V. Projections from vasopressin, oxytocin, and neurophysin neurons to neural targets in the rat and human. J Histochem Cytochem 1980, 28:475-478.
98. Spanakis E.K., Wand G.S., Ji N., Golden S.H. Association of HPA axis hormones with copeptin after psychological stress differs by sex. Psychoneuroendocrinology 2016, 63:254-261.
99. Stevenson E.L., Caldwell H.K. The vasopressin 1b receptor and the neural regulation of social behavior. Horm Behav 2012, 61:277-282.
100. Stoop R., Hegoburu C., van den Burg E. New opportunities in vasopressin and oxytocin research: a perspective from the amygdala. Annu Rev Neurosci 2015, 38:369-388.
101. Suzuki H., Kawasaki M., Ohnishi H., Nakamura T., Ueta Y. Regulatory mechanism of the arginine vasopressin-enhanced green fluorescent protein fusion gene expression in acute and chronic stress. Peptides 2009, 30:1763-1770.
102. Suzuki H., Kawasaki M., Ohnishi H., et al. Exaggerated response of a vasopressin-enhanced green fluorescent protein transgene to nociceptive stimulation in the rat. J Neurosci 2009, 29:13182-13189.
103. Suzuki H., Onaka T., Kasai M., et al. Response of arginine vasopressin-enhanced green fluorescent protein fusion gene in the hypothalamus of adjuvant-induced arthritic rats. J Neuroendocrinol 2009, 21:183-190.
104. Swaab D.F., Bao A.M., Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 2005, 4:141-194.
105. Swanson L.W., Sawchenko P.E., Lind R.W., Rho J.H. The CRH motoneuron: differential peptide regulation in neurons with possible synaptic, paracrine, and endocrine outputs. Ann NY Acad Sci 1987, 512:12-23.
106. Tasevska I., Enhorning S., Persson M., Nilsson P.M., Melander O. Copeptin predicts coronary artery disease cardiovascular and total mortality. Heart 2016, 102:127-132.
107. Tilders F.J.H., Berkenbosch F., Vermes I., Linton E.A., Smelik P.G. Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress. Fed Proc (FASEB) 1985, 44:155-160.
108. Ueta Y., Fujihara H., Serino R., et al. Transgenic expression of enhanced green fluorescent protein enables direct visualization for physiological studies of vasopressin neurons and isolated nerve terminals of the rat. Endocrinology 2005, 146:406-413.
109. Urwyler S.A., Schuetz P., Sailer C., Christ-Crain M. Copeptin as a stress marker prior and after a written examination-the CoEXAM study. Stress 2015, 18:134-137.
110. van Leeuwen F.W., Verwer R.W., Spence H., Evans D.A., Burbach J.P. The magnocellular neurons of the hypothalamo-neurohypophyseal system display remarkable neuropeptidergic phenotypes leading to novel insights in neuronal cell biology. Prog Brain Res 1998, 119:115-126.
111. Vargas K.J., Sarmiento J.M., Ehrenfeld P., et al. Postnatal expression of V2 vasopressin receptor splice variants in the rat cerebellum. Differentiation 2009, 77:377-385.
112. Veenema A.H., Neumann I.D. Neurobiological mechanisms of aggression and stress coping: a comparative study in mouse and rat selection lines. Brain Behav Evol 2007, 70:274-285.
113. Verney E.B. Absorption and excretion of water; the antidiuretic hormone. Lancet 1946, 2(739):781.
114. Vischer H.F., Castro M., Pin J.-P. G protein-coupled receptor multimers: a question still open despite the use of novel approaches. Mol Pharmacol 2015, 88:561-571.
115. von Bardeleben U., Holsboer F. Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression. J Neuroendocrinol 1989, 1:485-488.
116. Wrobel L.J., Dupre A., Raggenbass M. Excitatory action of vasopressin in the brain of the rat: role of cAMP signaling. Neuroscience 2011, 172:177-186.
117. Young S.F., Griffante C., Aguilera G. Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors. Cell Mol Neurobiol 2007, 27:439-461.
118. Zhu W., Tilley D.G., Myers V.D., Coleman R.C., Feldman A.M. Arginine vasopressin enhances cell survival via a G protein-coupled receptor kinase 2/beta-arrestin1/extracellular-regulated kinase 1/2-dependent pathway in H9c2 cells. Mol Pharmacol 2013, 84:227-235.
119. Ziegler D.R., Herman J.P. Neurocircuitry of stress integration: anatomical pathways regulating the hypothalamo-pituitary-adrenocortical axis of the rat. Integr Comp Biol 2002, 42:541-551.
120. Zimmerman E.A., Nilaver G., Hou-Yu A., Silverman A.J. Vasopressinergic and oxytocinergic pathways in the central nervous system. Fed Proc 1984, 43:91-96.